Ed Silverman is a prize-winning journalist who has covered the pharmaceutical industry for the past 14 years. Currently, he is a bureau chief for The Pink Sheet, the venerable industry newsletter, and a contributor to its sister publication, In Vivo magazine.

Before that, Silverman worked as a business writer for The Star-Ledger of New Jersey, one of the nation’s largest daily newspapers, where he conceived and launched Pharmalot. During his 13-year tenure, he closely followed a variety of topics of concern to those who work for, and with, drug makers - drug development; mergers and acquisitions; regulatory oversight; safety and pricing controversies, and marketing issues.

Prior to joining The Star-Ledger, Silverman spent six years at New York Newsday and previously worked at Investor’s Business Daily, among other newspapers. He has a master’s degree in journalism from New York University and a bachelor’s degree in accounting from Binghamton University. Although tethered to his laptop and Blackberry, Silverman lives in suburban New Jersey with his wife, three children and one sizeable labrador retriever.

Recognition

Pharmalot was awarded Third Place in the Online/Trade category by the Association of Health Care Journalists for its May 2007 series entitled “Improper Marketing As An Infectious Disease,” which detailed allegations that Pfizer sales reps were encouraged to use inappropriate business practices to boost sales of an older AIDS drug.

Pharmalot is independently owned and operated by Nojasa LLC. All rights reserved.

Other faces

If you have any technical problems (like not being to sign up for our email list) or suggestions, please write ed@pharmalot.com Thanks to Michael Tang at SpiderWebStudio for maintaining the site and FreePDFHosting for making some links possible